Army Medicine / Flickr Creative Commons

An agreement announced Wednesday between drug firm Pacira Pharmaceuticals and medical device company DePuy Synthes shows how the chase for revenue still dominates the health care industry.

The basics: DePuy, part of Johnson & Johnson, makes implants and devices for orthopedic procedures, such as hip and knee replacements. Pacira makes a painkiller called Exparel, which is injected in the patient during surgery to prolong pain relief after the surgery.

According to the deal, DePuy will add more sales reps to peddle Exparel to orthopedic surgeons who use DePuy devices. In exchange for the hopeful boost in revenue, Pacira will pay DePuy a percentage of its Exparel sales. Jason Gerberry, an analyst at Leerink Partners, estimates Pacira will pay DePuy between $10 million and $20 million per year.

Between the lines: Pacira said this deal fits with its "mission" of alleviating the opioid crisis by helping minimize the use of opioids for post-surgical pain. But at its core, this is a way to boost drug sales, and it's unclear if it'll save the health care system any money. Some hospitals and orthopedic surgeons have stopped using Exparel because of its high cost and questionable value, as STAT has reported.

Go deeper

Updated 10 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 4 p.m. ET: 31,175,205 — Total deaths: 962,076— Total recoveries: 21,294,229Map.
  2. U.S.: Total confirmed cases as of 4 p.m. ET: 6,829,956 — Total deaths: 199,690 — Total recoveries: 2,590,695 — Total tests: 95,121,596Map.
  3. Health: CDC says it mistakenly published guidance about COVID-19 spreading through air.
  4. Media: Conservative blogger who spread COVID-19 misinformation worked for Fauci's agency.
  5. Politics: House Democrats file legislation to fund government through Dec. 11.
  6. World: "The Wake-Up Call" warns the West about the consequences of mishandling a pandemic.

McConnell: Senate has "more than sufficient time" to process Supreme Court nomination

Senate Majority Leader Mitch McConnell (R-Ky.) said in a floor speech Monday that the chamber has "more than sufficient time" to confirm a replacement for Supreme Court Justice Ruth Bader Ginsburg before the election, and accused Democrats of preparing "an even more appalling sequel" to the fight over Brett Kavanaugh's confirmation.

Why it matters: Senate Minority Leader Chuck Schumer (D-N.Y.) has said "nothing is off the table next year" if Republicans push ahead with the confirmation vote before November, vowing alongside Rep. Alexandria Ocasio-Cortez (D-N.Y.) to use "every procedural tool available to us to ensure that we buy ourselves the time necessary."

House Democrats file legislation to fund government through Dec. 11

House Speaker Nancy Pelosi (D-Calif.). Photo: Chip Somodevilla/Getty Images

House Democrats on Monday released their proposal for short-term legislation to fund the government through December 11.

Why it matters: This is Congress' chief legislative focus before the election. They must pass a continuing resolution (CR) before midnight on Oct. 1 to avoid a government shutdown — something both Hill leaders and the White House have claimed is off the table.